Literature DB >> 22733365

Arrhythmia-associated cardiac Ca²(+) cycling proteins and gene mutations.

Simon Kochhäuser1, Eric Schulze-Bahr, Uwe Kirchhefer.   

Abstract

Calcium is an important mediator in cardiac excitation and disorders in cardiac Ca(2+) homeostasis have great influence on the cardiac action potential. Therefore dysfunction in regulatory proteins that are involved in Ca(2+) handling can lead to the occurrence of severe arrhythmia. Although mutations in Ca(2+) regulating proteins are quite rare, they can offer general insights into arrhythmogenesis. Here, we briefly review some important aspects of arrhythmia-associated mutations in Ca(2+) regulating proteins with special emphasis to its associated pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733365     DOI: 10.1007/s10354-012-0114-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  29 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

Review 2.  Calcium cycling in congestive heart failure.

Authors:  Gerd Hasenfuss; Burkert Pieske
Journal:  J Mol Cell Cardiol       Date:  2002-08       Impact factor: 5.000

3.  Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Authors:  A V Postma; I Denjoy; J Kamblock; M Alders; J-M Lupoglazoff; G Vaksmann; L Dubosq-Bidot; P Sebillon; M M A M Mannens; P Guicheney; A A M Wilde
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

4.  Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.

Authors:  Heikki Swan; Päivi Laitinen; Kimmo Kontula; Lauri Toivonen
Journal:  J Cardiovasc Electrophysiol       Date:  2005-02

Review 5.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

6.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

7.  Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium.

Authors:  Timothy D Houle; Michal L Ram; Steven E Cala
Journal:  Cardiovasc Res       Date:  2004-11-01       Impact factor: 10.787

8.  Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.

Authors:  Christopher H George; Gemma V Higgs; F Anthony Lai
Journal:  Circ Res       Date:  2003-08-14       Impact factor: 17.367

9.  Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.

Authors:  Hiroshi Watanabe; Nagesh Chopra; Derek Laver; Hyun Seok Hwang; Sean S Davies; Daniel E Roach; Henry J Duff; Dan M Roden; Arthur A M Wilde; Björn C Knollmann
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

10.  Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Authors:  Silvia G Priori; Carlo Napolitano; Peter J Schwartz; Massimiliano Grillo; Raffaella Bloise; Elena Ronchetti; Cinzia Moncalvo; Chiara Tulipani; Alessia Veia; Georgia Bottelli; Janni Nastoli
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  1 in total

Review 1.  Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.

Authors:  Jeanne M Nerbonne
Journal:  Curr Opin Pharmacol       Date:  2014-03-13       Impact factor: 5.547

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.